Medroxyprogesterone Acetate
- Product NDC
- 16714-028
- 11-digit product format
- 167140028
- Labeler code
- 16714
- Product ID
- 16714-028_a5922196-219d-413f-96aa-98ec6bfbea00
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Medroxyprogesterone Acetate
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Northstar RxLLC
- Application
- ANDA076553
- Marketing category
- ANDA
- Marketing start
- 2021-11-09
- Marketing end
- 0000-00-00
- Substance
- MEDROXYPROGESTERONE ACETATE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-028-01 | 16714002801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-028-01) > 1 mL in 1 VIAL, SINGLE-DOSE | 2021-11-09 | 0000-00-00 | No | No | Current |
| 16714-028-25 | 16714002825 | 25 VIAL, SINGLE-DOSE in 1 CARTON (16714-028-25) > 1 mL in 1 VIAL, SINGLE-DOSE | 2021-11-09 | 0000-00-00 | No | No | Current |